What You Should Know:
- myTomorrows, a health technology company that connects patients with all possible pre-approval treatments, today announced the close of a $29 million financing with Avego. Avego’s growth equity investment will fuel the global expansion of myTomorrows’ integrated pharma solutions to make emerging treatments more equitable and accessible for patients globally.
- With more than 300 million patients worldwide facing conditions without approved treatment options, and
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Onchilles Pharma Raises $25M to Advance N17350, Pioneering Next-Gen Cytotoxic Cancer Therapy
What You Should Know:
- Onchilles Pharma, a private biotech company pioneering next-generation cytotoxic therapeutics announced the publication of foundational preclinical data in the peer-reviewed journal Cell Reports Medicine, the close of a $25M Series A1 financing round.
- In addition, the company appointed Dr. Thomas A. Buchholz as a clinical advisor. The funding brings the total raised in Series A financing to $40M.
Foundational Preclinical Data Validates Cancer-Selective
Read More
The Agentic Workforce: 10 New AI Roles Transforming Life Sciences Operations by 2032
As AI agents move from concept to colleague, the life sciences workforce is about to expand – no desks required.
While much of the activity is still in testing phases, AI agents are already making a difference in specific, high-return areas. AI is being used for processing and sorting pharmacovigilance (PV) reports, drafting medical and regulatory documents, assisting with lab operations, inspecting product quality, and helping employees find internal information.
The coming year will see
Read More
Flatiron Launches 6 AI-Powered Hematology Datasets to Advance Blood Cancer RWE
What You Should Know:
-Flatiron Health, a leading healthtech company dedicated to improving cancer care and advancing research using real-world data, today announced the launch of six new hematology Panoramic datasets, representing another critical moment of scientific innovation that foundationally redefines the company's real-world evidence offerings in blood cancers.
- Flatiron’s Panoramic data unlocks the company’s entire patient network, leveraging breakthrough AI and large language
Read More
Verily and NVIDIA Announce Strategic Collaboration to Accelerate AI in Precision Health
What You Should Know:
- Verily, a precision health AI company, today announced a collaboration with NVIDIA to integrate NVIDIA’s complete AI technology stack into its Pre platform.
- The strategic integration is designed to help Verily’s health system, life science, payer, and government customers and partners more efficiently develop and deploy AI across healthcare.
Unparalleled Acceleration for Omics and AI Development
The collaboration provides researchers with
Read More
NVIDIA Unveils New AI Platform and Partnerships to Accelerate Scientific Discovery and Operationalize Healthcare Intelligence
What You Should Know:
- NVIDIA today unveiled a massive expansion of its healthcare AI initiatives, rolling out new open models as part of the NVIDIA Clara platform and announcing foundational partnerships with industry giants like Lilly and Innovaccer.
- These advancements are set to accelerate scientific discovery, transform complex surgical procedures using digital twins, and embed real-time intelligence into clinical and operational workflows.
Pharma 4.0: Lilly Builds
Read More
Cybersecurity Challenges in AI-Driven Pharmaceutical Manufacturing: Lessons from the Frontlines
The pharmaceutical industry is undergoing a digital transformation like never before. Emerging technologies such as artificial intelligence, the internet of things, and real-time analytics have revolutionized manufacturing. Predictive maintenance, intelligent batch scheduling, and machine learning enhanced inspections have created a modern production floor that is smarter, faster, and more connected.
This transformation, however, comes with an underestimated cost: cybersecurity risk.
Read More
Sponsored Article: Biosimilars Expand Access to Essential Biological Therapies
Biologic medicines have transformed modern healthcare, but their high cost continues to limit access for many patients worldwide. Biosimilars - biologic therapies shown to be highly similar to existing reference products - offer a powerful solution by introducing competition and reducing drug prices. Their adoption is already reshaping treatment landscapes, with proven cost savings and expanded patient access in key therapeutic areas. As regulatory frameworks evolve, biosimilars are positioned
Read More
Weave Bio Raises $20M to Scale AI-Native Regulatory Automation Platform
What You Should Know:
- Weave Bio, a pioneer in AI-native regulatory automation management solutions announced it has raised $20M in Series A funding, bringing the company’s total capital raised to $36M led by USVP, with participation from Innovation Endeavors, Magnetic Ventures, Character, TMV, and Serrado Capital.
- The investment is set to accelerate the company’s mission to transform how novel therapies navigate the complex path from the lab to the global market.
Transforming
Read More
Caravel Bio Wins $7.8M NSF Grant to Pioneer Next-Generation Protein Engineering
What You Should Know:
- Caravel Bio, the first joint platform for protein discovery and delivery that enables new applications of synthetic biology, today announces its selection for a $7.8M award from the U.S. National Science Foundation Directorate for Technology, Innovation and Partnerships (NSF TIP).
- The award assembles a team of world-class engineers to create tools for building proteins with novel chemistries, train more advanced machine learning models on the resulting datasets,
Read More
